Narrow search
Showing 1 - 10 of 113
Cover Image
Pharmaceutical patents : incentives for R&D or marketing?
Brekke, Kurt R. (contributor); Straume, Odd Rune (contributor) - 2008
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R … industry. Within a fairly general model framework, we derive exact conditions for advertising and R&D being substitute … strategies for the incumbent firm and show that it may overinvest in advertising to reduce the incentive for an entrant to invest …
Persistent link: https://www.econbiz.de/10003771873
Cover Image
Pharmaceutical patents: incentives for research and development or marketing?
Brekke, Kurt R.; Straume, Odd Rune - In: Southern economic journal 76 (2009) 2, pp. 351-374
Persistent link: https://www.econbiz.de/10003903146
Cover Image
Pharmaceutical Patents : Incentives for R&D or Marketing?
Brekke, Kurt Richard; Straume, Odd Rune - 2021
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R … industry. Within a fairly general model framework, we derive exact conditions for advertising and R&D being substitute … strategies for the incumbent firm and show that it may overinvest in advertising to reduce the incentive for an entrant to invest …
Persistent link: https://www.econbiz.de/10013316463
Cover Image
Pharmaceutical patents : incentives for R&D or marketing?
Brekke, Kurt R. (contributor); Straume, Odd Rune (contributor) - 2005
Persistent link: https://www.econbiz.de/10003209183
Cover Image
Does reference pricing drive out generic competition in pharmaceutical markets? : evidence from a policy reform
Brekke, Kurt R.; Canta, Chiara; Straume, Odd Rune - 2022
Policy makers use reference pricing to curb pharmaceutical expenditures by reducing coverage of expensive branded drugs. In a theoretical analysis we show that the net effect of reference pricing is generally ambiguous when accounting for entry by generic producers. Reference pricing shifts...
Persistent link: https://www.econbiz.de/10013285854
Cover Image
Margins and market shares : pharmacy incentives for generic substitution
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2012
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …. -- pharmaceuticals ; pharmacies ; generic substitution …
Persistent link: https://www.econbiz.de/10009691207
Cover Image
Reference pricing, competition, and pharmaceutical expenditures : theory and evidence from a natural experiment
Brekke, Kurt R.; Holmås, Tor Helge; Straume, Odd Rune - 2010
-savings, and that patients' copayments decrease despite the extra surcharges under RP. -- pharmaceuticals ; regulation ; generic …
Persistent link: https://www.econbiz.de/10008749029
Cover Image
Margins and Market Shares : Pharmacy Incentives for Generic Substitution
Brekke, Kurt Richard - 2010
We study the impact of product margins on pharmacies' incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to purchase a generic version instead. We show that pharmacies' substitution...
Persistent link: https://www.econbiz.de/10013139185
Cover Image
Margins and Market Shares : Pharmacy Incentives for Generic Substitution
Brekke, Kurt Richard - 2013
generics and their market shares. This relationship is stronger for pharmaceuticals under reference pricing rather than …
Persistent link: https://www.econbiz.de/10013088216
Cover Image
Price Regulation and Parallel Imports of Pharmaceuticals
Brekke, Kurt Richard - 2015
This paper studies the effects of price regulation and parallel imports in the on-patent pharmaceutical market. In a theory model where the producer price is subject to bargaining between the brand-name producer and a distributor, we show that the effects of stricter price regulation crucially...
Persistent link: https://www.econbiz.de/10013017702